Sp139
POSITIONING ADVANCED IBD THERAPIES
Date
May 18, 2024
Explore related products in the following collection:
Presenter
University of Chicago Division of the Biological Sciences
Tracks
Related Products
ENVIRONMENTAL AND DIETARY FACTORS IN INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED CASE-CONTROL STUDY FROM THE GLOBAL INFLAMMATORY BOWEL DISEASE VISUALIZATION OF EPIDEMIOLOGY STUDIES IN THE 21ST CENTURY (GIVES-21) CONSORTIUM
OBJECTIVE:The rapid emergence of IBD in newly industrialized regions supports the importance of environmental risk factors in disease etiology…
THE EFFICACY AND SAFETY OF GUSELKUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR MAINTENANCE STUDY
The Phase 3 QUASAR Maintenance Study (NCT04033445) is a randomized-withdrawal, double-blind, placebo(PBO)-controlled, study that evaluated the efficacy and safety of maintenance treatment with subcutaneous (SC) guselkumab (GUS), an IL-23p19 subunit antagonist, in patients (pts) with moderately to s…
